Skip to main content

Table 4 Late urinary, rectal, and sexual function-related toxicities on LENT/SOMA scales after neoadjuvant chemoradiation

From: A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

LENT/SOMA grade

Urinary function

Rectal function

Sexual function

Num

%

Num

%

Num

%

0

22

75.86

26

89.66

24

82.76

1

5

17.24

2

6.90

5

17.24

2

2

6.90

1

3.45

0

0.00

3

0

0.00

0

0.00

0

0.00

4

0

0.00

0

0.00

0

0.00

  1. LENT/SOMA Late Effects on Normal Tissue / Subjective, Objective, Management and Analytic.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us